These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [The use of dopamin in shock and heart failure (author's transl)]. Aroński A, Kübler A, Sliwinski M, Paszkowska A. Anaesthesist; 1978 Apr; 27(4):183-6. PubMed ID: 655365 [Abstract] [Full Text] [Related]
5. Physiologic basis for the therapeutic use of catecholamines. Rosenblum R. Am Heart J; 1974 Apr; 87(4):527-30. PubMed ID: 4817111 [No Abstract] [Full Text] [Related]
6. [Catecholamines in the therapy of chronic cardiac insufficiency]. Brandt D, Klein W. Wien Med Wochenschr; 1982 Oct 15; 132(19):450-6. PubMed ID: 6294999 [No Abstract] [Full Text] [Related]
8. Use of catecholamines in acute myocardial infarction. Dixon DW, Loeb HS, Gunnar RM. Herz; 1979 Oct 15; 4(5):385-96. PubMed ID: 391685 [Abstract] [Full Text] [Related]
9. Dopamine: new uses for an old drug. Dipalma JR. Am Fam Physician; 1975 Apr 15; 11(4):149-51. PubMed ID: 1119364 [No Abstract] [Full Text] [Related]
10. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency]. Coulombe D. Ann Cardiol Angeiol (Paris); 1984 Apr 15; 33(4):207-10. PubMed ID: 6147113 [Abstract] [Full Text] [Related]
11. [The use of sympathomimetics and sympatholytics in shock]. Torsti P. Duodecim; 1971 Apr 15; 87(4):297-304. PubMed ID: 5547048 [No Abstract] [Full Text] [Related]
12. The failing myocardium. I. Drug management. Loeb HS, Rahimtoola SH, Gunnar RM. Med Clin North Am; 1973 Jan 15; 57(1):167-85. PubMed ID: 4143986 [No Abstract] [Full Text] [Related]
13. Comparison of dopamine and norepinephrine in shock. Romero CM. N Engl J Med; 2010 Jun 17; 362(24):2328; author reply 2330-1. PubMed ID: 20554990 [No Abstract] [Full Text] [Related]
14. [Currently used positive inotropic substances]. Hauf GF, Grom E. Ther Umsch; 1984 Feb 17; 41(2):111-6. PubMed ID: 6369614 [No Abstract] [Full Text] [Related]
15. [Sympathomimetics in intensive medicine]. Vogel F, Spannbrucker N, Bodem G. Dtsch Med Wochenschr; 1981 Oct 16; 106(42):1383-5. PubMed ID: 7285817 [No Abstract] [Full Text] [Related]
16. Cardiogenic shock: therapeutic implications of altered myocardial energy balance. Kones RJ. Angiology; 1974 May 16; 25(5):317-33. PubMed ID: 4150913 [No Abstract] [Full Text] [Related]
17. Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure. Potapov EV, Hennig F, Wagner FD, Volk HD, Sodian R, Hausmann H, Lehmkuhl HB, Hetzer R. Eur J Cardiothorac Surg; 2005 May 16; 27(5):899-905. PubMed ID: 15848333 [Abstract] [Full Text] [Related]
18. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?]. Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M. Dtsch Med Wochenschr; 2004 Sep 10; 129(37):1925-30. PubMed ID: 15372372 [Abstract] [Full Text] [Related]
19. Dopamine--clinical uses of an endogenous catecholamine. Goldberg LI. N Engl J Med; 1974 Oct 03; 291(14):707-10. PubMed ID: 4604342 [No Abstract] [Full Text] [Related]
20. [Basic principles of the therapy of shock]. Schröder R. Minerva Med; 1972 Dec 26; 63(93):5243-6. PubMed ID: 4646406 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]